| PERIOD ENDING | 2-Aug-08 | 3-May-08 | 2-Feb-08 | 3-Nov-07 | | Total Revenue | 3,499,000 | 3,384,000 | 4,675,000 | 3,854,000 | | Cost of Revenue | 2,161,000 | 2,042,000 | 3,049,000 | 2,407,000 | | | Gross Profit | 1,338,000 | 1,342,000 | 1,626,000 | 1,447,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 965,000 | 959,000 | 1,208,000 | 1,079,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 373,000 | 383,000 | 418,000 | 368,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | 25,000 | 20,000 | 28,000 | | Earnings Before Interest And Taxes | 377,000 | 408,000 | 438,000 | 396,000 | | Interest Expense |
-
|
-
| 5,000 | 1,000 | | Income Before Tax | 377,000 | 408,000 | 433,000 | 395,000 | | Income Tax Expense | 148,000 | 159,000 | 168,000 | 156,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 229,000 | 249,000 | 265,000 | 239,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (2,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 229,000 | 249,000 | 265,000 | 237,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $229,000 | $249,000 | $265,000 | $237,000 |
|
4.73% Nasdaq 
Income Statement
